CAMP and fatty liver disease: Collectively (Figure 6F), we have shown in our study that the deletion of Camp protects mice against HFDE-induced liver steatosis, injury and inflammation through upregulating FGF21/adiponectin signaling and increasing adipose lipolysis in the eWAT.